본문 바로가기
KERD
논문KCI 등재

Cerebro-/Cardiovascular Collateral Damage During the COVID-19 Pandemic: Fact or Fiction?

Georgios Tsivgoulis|Sotirios Giannopoulos|Christos S. Katsouras|Michail I Papafaklis|Theodoros Karapanayiotides|Lampros K Michalis
대한신경과학회 (Korean Neurological Association)|2023.01|Journal of Clinical Neurology|제19권 제1호|pp. 1-11

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

strokeCOVID-19 pandemiccollateral damageacute coronary syndrome

초록

Numerous observational studies have identified a decline in cerebro-/cardiovascular (CV) admissions during the initial phase of the COVID-19 pandemic. Recent studies and meta-analyses indicated that the overall decrease was smaller than that found in initial studies during the first months of 2020. Two years later we still do not have clear evidence about the potential causes and impacts of the reduction of CV hospitalizations during the COVID-19 pandemic. It has becoming increasingly evident that collateral damage (i.e., incidental damage to the public and patients) from the COVID-19 outbreak is the main underlying cause that at least somewhat reflects the effects of imposed measures such as social distancing and self-isolation. However, a smaller true decline in CV events in the community due to a lack of triggers associated with such acute syndromes cannot be excluded. There is currently indirect epidemiological evidence about the immediate impact that the collateral damage had on excess mortality, but possible late consequences including a rebound increase in CV events are yet to be observed. In the present narrative review, we present the reporting milestones in the literature of the rates of CV admissions and collateral damage during the last 2 years, and discuss all possible factors contributing to the decline in CV hospitalizations during the COVID-19 pandemic. Healthcare systems need to be prepared so that they can cope with the increased hospitalization rates for CV events in the near future.

Abstract

Numerous observational studies have identified a decline in cerebro-/cardiovascular (CV) admissions during the initial phase of the COVID-19 pandemic. Recent studies and meta-analyses indicated that the overall decrease was smaller than that found in initial studies during the first months of 2020. Two years later we still do not have clear evidence about the potential causes and impacts of the reduction of CV hospitalizations during the COVID-19 pandemic. It has becoming increasingly evident that collateral damage (i.e., incidental damage to the public and patients) from the COVID-19 outbreak is the main underlying cause that at least somewhat reflects the effects of imposed measures such as social distancing and self-isolation. However, a smaller true decline in CV events in the community due to a lack of triggers associated with such acute syndromes cannot be excluded. There is currently indirect epidemiological evidence about the immediate impact that the collateral damage had on excess mortality, but possible late consequences including a rebound increase in CV events are yet to be observed. In the present narrative review, we present the reporting milestones in the literature of the rates of CV admissions and collateral damage during the last 2 years, and discuss all possible factors contributing to the decline in CV hospitalizations during the COVID-19 pandemic. Healthcare systems need to be prepared so that they can cope with the increased hospitalization rates for CV events in the near future.

참고문헌 (96)

  1. Schelling TC, "Dispersal, deterrence, and damage", Oper Res, 9, pp.363~370 (1961)
  2. Dupraz J, "Early impact of the COVID-19 pandemic on in-person outpatient care utilisation : a rapid review", BMJ Open, 12, pp.e056086~ (2022)
  3. Xu S, "Impact of the COVID-19 pandemic on health care utilization in a large integrated health care system : retrospective cohort study", J Med Internet Res, 23, pp.e26558~ (2021)
  4. Whaley CM, "Changes in health services use among commercially insured US populations during the COVID-19 pandemic", JAMA Netw Open, 3, pp.e2024984~ (2020)
  5. De Filippo O, "Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy", N Engl J Med, 383, pp.88~89 (2020)
  6. Metzler B, "Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19 : the pandemic response causes cardiac collateral damage", Eur Heart J, 41, pp.1852~1853 (2020)
  7. Morelli N, "The baffling case of ischemic stroke disappearance from the casualty department in the COVID-19 era", Eur Neurol, 83, pp.213~215 (2020)
  8. Rodriguez-Leor O, "Impact of the COVID-19pandemic on interventional cardiology activity in Spain", REC Interv Cardiol, 2, pp.82~89 (2020)
  9. Garcia S, "Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic", J Am Coll Cardiol, 75, pp.2871~2872 (2020)
  10. Caso V, "No lockdown for neurological diseases during COVID19 pandemic infection", Neurol Sci, 41, pp.999~1001 (2020)
  11. "COVID-19: a message from those living with neurological disorders" (2020)[URL]
  12. Diegoli H, "Decrease in hospital admissions for transient ischemic attack, mild, and moderate stroke during the COVID-19 era", Stroke, 51, pp.2315~2321 (2020)
  13. Hoyer C, "Acute stroke in times of the COVID-19 pandemic : a multicenter study", Stroke, 51, pp.2224~2227 (2020)
  14. Jasne AS, "Stroke code presentations, interventions, and outcomes before and during the COVID-19 pandemic", Stroke, 51, pp.2664~2673 (2020)
  15. Katsouras C, "Greater decline of acute stroke admissions compared with acute coronary syndromes during COVID-19 outbreak in Greece : cerebro", cardiovascular implications amidst a second wave surge, 2021, pp.28, 3452~3455
  16. Katsouras C, "Persistent decline of hospitalizations for acute stroke and acute coronary syndrome during the second wave of the COVID-19 pandemic in Greece : collateral damage unaffected", Ther Adv Neurol Disord, 14, pp.17562864211029540~ (2021)
  17. Mafham MM, "COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England", Lancet, 396, pp.381~389 (2020)
  18. Østergaard L, "Incidence of acute coronary syndrome during national lock-down : insights from nationwide data during the coronavirus disease 2019(COVID-19)pandemic", Am Heart J, 232, pp.146~153 (2021)
  19. Papafaklis MI, ""Missing"acute coronary syndrome hospitalizations during the COVID-19 era in Greece : medical care avoidance combined with a true reduction in incidence?", Clin Cardiol, 43, pp.1142~1149 (2020)
  20. Richter D, "A full year of the COVID-19 pandemic with two infection waves and its impact on ischemic stroke patient care in Germany", Eur J Neurol, 29, pp.105~113 (2022)
  21. Rudilosso S, "Acute stroke care is at risk in the era of COVID-19 : experience at a comprehensive stroke center in Barcelona", Stroke, 51, pp.1991~1995 (2020)
  22. Siegler JE, "Falling stroke rates during COVID-19 pandemic at a comprehensive stroke center", J Stroke Cerebrovasc Dis, 29, pp.104953~ (2020)
  23. Wu J, "Second decline in admissions with heart failure and myocardial infarction during the COVID-19 pandemic", J Am Coll Cardiol, 77, pp.1141~1143 (2021)
  24. Richter D, "Analysis of nationwide stroke patient care in times of COVID-19 pandemic in Germany", Stroke, 52, pp.716~721 (2021)
  25. Montaner J, "Break in the stroke chain of survival due to COVID-19", Stroke, 51, pp.2307~2314 (2020)
  26. Nogueira RG, "Global impact of COVID-19 on stroke care", Int J Stroke, 16, pp.573~584 (2021)
  27. Nogueira RG, "Global impact of COVID-19 on stroke care and IV thrombolysis", Neurology, 96, pp.e2824~e2838 (2021)
  28. Nguyen TN, "Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic", Stroke Vasc Neurol, 6, pp.542~552 (2021)
  29. Yang Q, "Stroke hospitalizations before and during COVID-19 pandemic among Medicare beneficiaries in the United States", Stroke, 52, pp.3586~3601 (2021)
  30. Lin G, "A longitudinal research on the distribution and prognosis of intracerebral hemorrhage during the COVID-19 pandemic", Front Neurol, 13, pp.873061~ (2022)
  31. Chan DZ, "The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand(ANZACS-QI 55)", Lancet Reg Health West Pac, 5, pp.100056~ (2020)
  32. Collyer TA, "Impact of COVID-19 lockdowns on hospital presentations and admissions in the context of low community transmission : evidence from time series analysis in Melbourne, Australia", J Epidemiol Community Health, 76, pp.341~349 (2022)
  33. Fanaroff AC, "Myocardial infarction during the COVID-19 pandemic", JAMA, 326, pp.1916~1918 (2021)
  34. Nishiga M, "COVID-19 and cardiovascular disease : from basic mechanisms to clinical perspectives", Nat Rev Cardiol, 17, pp.543~558 (2020)
  35. Taquet M, "6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19 : a retrospective cohort study using electronic health records", Lancet Psychiatry, 8, pp.416~427 (2021)
  36. Xie Y, "Long-term cardiovascular outcomes of COVID-19", Nat Med, 28, pp.583~590 (2022)
  37. Qureshi AI, "Acute ischemic stroke and COVID-19 : an analysis of 27 676 patients", Stroke, 52, pp.905~912 (2021)
  38. 박진우, "Lessons from COVID-19 in Clinical Neurology", Journal of Clinical Neurology, 18(1), pp.1~2 (2022), 대한신경과학회
  39. Panigada M, "Hypercoagulability of COVID-19 patients in intensive care unit : a report of thromboelastography findings and other parameters of hemostasis", J Thromb Haemost, 18, pp.1738~1742 (2020)
  40. Jevtic SD, "The COVID complex : a review of platelet activation and immune complexes in COVID-19", Front Immunol, 13, pp.807934~ (2022)
  41. Varga Z, "Endothelial cell infection and endotheliitis in COVID-19", Lancet, 395, pp.1417~1418 (2020)
  42. COVID-19 Host Genetics Initiative, "Mapping the human genetic architecture of COVID-19", Nature, 600, pp.472~477 (2021)
  43. Nannoni S, "Stroke in COVID-19 : a systematic review and meta-analysis", Int J Stroke, 16, pp.137~149 (2021)
  44. Dmytriw AA, "Acute ischaemic stroke associated with SARS-CoV-2 infection in North America", J Neurol Neurosurg Psychiatry, 93, pp.360~368 (2022)
  45. Martí-Fàbregas J, "Impact of COVID-19 infection on the outcome of patients with ischemic stroke", Stroke, 52, pp.3908~3917 (2021)
  46. Baumhardt M, "The effect of the lockdown on patients with myocardial infarction during the COVID-19 pandemic : a systematic review and meta-analysis", Dtsch Arztebl Int, 118, pp.447~453 (2021)
  47. Zhu Y, "Characteristics of patients with ST-segment elevated myocardial infarction (STEMI) at the initial stage of the COVID-19 pandemic: a systematic review and meta-analysis", Infect Dis(Lond), 53, pp.865~875 (2021)
  48. Helal A, "Global effect of COVID-19 pandemic on the rate of acute coronary syndrome admissions : a comprehensive review of published literature", Open Heart, 8, pp.e001645~ (2021)
  49. Sofi F, "Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19 : a systematic review and meta-analysis", Int J Cardiol, 347, pp.89~96 (2022)
  50. Rattka M, "Effect of the COVID-19 pandemic on mortality of patients with STEMI : a systematic review and meta-analysis", Heart, 107, pp.482~487 (2021)
  51. July J, "Impact of the coronavirus disease pandemic on the number of strokes and mechanical thrombectomies : a systematic review and meta-analysis", J Stroke Cerebrovasc Dis, 29, pp.105185~ (2020)
  52. Romoli M, "Stroke network performance during the first COVID-19 pandemic stage : a meta-analysis based on stroke network models", Int J Stroke, 16, pp.771~783 (2021)
  53. Reddy ST, "A meta-analysis of the global impact of the COVID-19pandemic on stroke care & the Houston experience", Ann Clin Transl Neurol, 8, pp.929~937 (2021)
  54. Katsanos AH, "Changes in stroke hospital care during the COVID-19 pandemic : a systematic review and meta-analysis", Stroke, 52, pp.3651~3660 (2021)
  55. You Y, "Impact of COVID-19 pandemic on haemorrhagic stroke admissions : a systematic review and meta-analysis", BMJ Open, 11, pp.e050559~ (2021)
  56. Noman Ishaque, "Trends in Stroke Presentations before and during the COVID-19 Pandemic: A Meta-Analysis", 대한뇌졸중영문학회지, 24(1), pp.65~78 (2022), 대한뇌졸중학회[DOI]
  57. Desai R, "Significantly higher odds of mortality in stroke-related admissions during COVID-19 pandemic versus pre-COVID", pandemic : a meta-analysis of 455, 073 stroke admissions, 2022, pp.53(Suppl_1), A54~
  58. Solomon MD, "The Covid-19 pandemic and the incidence of acute myocardial infarction", N Engl J Med, 383, pp.691~693 (2020)
  59. Uchino K, "Decline in stroke presentations during COVID-19 surge", Stroke, 51, pp.2544~2547 (2020)
  60. Ganesh A, "Changes in ischemic stroke presentations, management and outcomes during the first year of the COVID-19 pandemic in Alberta : a population study", CMAJ, 194, pp.E444~E455 (2022)
  61. Sweeney K, "Crisis decision theory : decisions in the face of negative events", Psychol Bull, 134, pp.61~76 (2008)
  62. Bodilsen J, "Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic : nationwide population based cohort study", BMJ, 373, pp.n1135~ (2021)
  63. Chew NWS, "The global effect of the COVID-19 pandemic on STEMI care : a systematic review and meta-analysis", Can J Cardiol, 37, pp.1450~1459 (2021)
  64. Schirmer CM, "Delayed presentation of acute ischemic strokes during the COVID-19 crisis", J Neurointerv Surg, 12, pp.639~642 (2020)
  65. Rajagopalan S, "Air pollution and cardiovascular disease : JACC state-of-the-art review", J Am Coll Cardiol, 72, pp.2054~2070 (2018)
  66. Le T, "Unexpected air pollution with marked emission reductions during the COVID-19 outbreak in China", Science, 369, pp.702~706 (2020)
  67. Claeys MJ, "Impact of COVID-19-related public containment measures on the ST elevation myocardial infarction epidemic in Belgium : a nationwide, serial, cross-sectional study", Acta Cardiol, 76, pp.863~869 (2021)
  68. Andersen ZJ, "Air pollution and COVID-19 : clearing the air and charting a post-pandemic course : a joint workshop report of ERS, ISEE, HEI and WHO", Eur Respir J, 58, pp.2101063~ (2021)
  69. Adlhoch C, "What to expect for the influenza season 2020", 21with the ongoing COVID-19 pandemic in the World Health Organization European Region, 2020, pp.25, 2001816~
  70. Kwong JC, "Acute myocardial infarction after laboratoryconfirmed influenza infection", N Engl J Med, 378, pp.345~353 (2018)
  71. Warren-Gash C, "Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease : a systematic review", Lancet Infect Dis, 9, pp.601~610 (2009)
  72. Boehme AK, "Influenza-like illness as a trigger for ischemic stroke", Ann Clin Transl Neurol, 5, pp.456~463 (2018)
  73. Katsoularis I, "Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden : a self-controlled case series and matched cohort study", Lancet, 398, pp.599~607 (2021)
  74. "Estimated flu-related illnesses, medical visits, hospitalizations, and deaths in the United States—2018-2019 flu season" (2021)[URL]
  75. "COVID data tracker" (2022)[URL]
  76. Merkler AE, "Risk of ischemic stroke in patients with coronavirus disease 2019(COVID-19)vs patients with influenza", JAMA Neurol, 77, pp.1366~1372 (2020)
  77. Stals MAM, "Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients", Res Pract Thromb Haemost, 5, pp.412~420 (2021)
  78. Tsigkas G, "Potential relationship between lifestyle changes and incidence of hospital admissions for acute coronary syndrome during the COVID-19 lockdown", Front Cardiovasc Med, 8, pp.604374~ (2021)
  79. Pollard MS, "Changes in adult alcohol use and consequences during the COVID-19 pandemic in the US", JAMA Netw Open, 3, pp.e2022942~ (2020)
  80. COVID-19 Mental Disorders Collaborators, "Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic", Lancet, 398, pp.1700~1712 (2021)
  81. Wadhera RK, "Racial and ethnic disparities in heart and cerebrovascular disease deaths during the COVID-19 pandemic in the United States", Circulation, 143, pp.2346~2354 (2021)
  82. Driscoll AK, "Health and access to care among employed and unemployed adults : United States, 2009-2010", NCHS Data Brief, 83, pp.1~8 (2012)
  83. Baldi E, "COVID-19 kills at home : the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests", Eur Heart J, 41, pp.3045~3054 (2020)
  84. Fothergill RT, "Out-of-hospital cardiac arrest in London during the COVID-19 pandemic", Resusc Plus, 5, pp.100066~ (2021)
  85. "Excess mortality-statistics" (2022)[URL]
  86. "The true death toll of COVID-19. Estimating global excess mortality" (2022)[URL]
  87. Kontopantelis E, "Excess mortality in England and Wales during the first wave of the COVID-19pandemic", J Epidemiol Community Health, 75, pp.213~223 (2021)
  88. Woolf SH, "Excess deaths from COVID-19 and other causes, March-July 2020", JAMA, 324, pp.1562~1564 (2020)
  89. Ahmad FB, "The leading causes of death in the US for 2020", JAMA, 325, pp.1829~1830 (2021)
  90. Piccininni M, "Use of all cause mortality to quantify the consequences of covid-19 in Nembro, Lombardy : descriptive study", BMJ, 369, pp.m1835~ (2020)
  91. Stokes AC, "COVID-19 and excess mortality in the United States : a county-level analysis", PLoS Med, 18, pp.e1003571~ (2021)
  92. Weinberger DM, "Estimation of excess deaths associated with the COVID-19pandemic in the United States, March to May 2020", JAMA Intern Med, 180, pp.1336~1344 (2020)
  93. Iuliano AD, "Estimating under-recognized COVID-19 deaths, United States, march 2020-may 2021 using an excess mortality modelling approach", Lancet Reg Health Am, 1, pp.100019~ (2021)
  94. Walsh J, "Telemedicine for follow-up of rare neurological disease", Stroke, 50, pp.750~753 (2019)
  95. Meyer BC, "Efficacy of site-independent telemedicine in the STRokE DOC trial : a randomised, blinded, prospective study", Lancet Neurol, 7, pp.787~795 (2008)
  96. Burns SP, "Stroke recovery during the COVID-19 pandemic : a position paper on recommendations for rehabilitation", Arch Phys Med Rehabil, 103, pp.1874~1882 (2022)

관련 논문AI추천

Therapeutic Trends of Cerebrovascular Disease during the COVID-19 Pandemic and Future PerspectivesJames E. Siegler, Mohamad Abdalkader, Patrik Michel, Thanh N. Nguyen대한뇌졸중학회 · 대한뇌졸중영문학회지2022 · 제24권 제2호Trends in Stroke Presentations before and during the COVID-19 Pandemic: A Meta-AnalysisAli Zohair Nomani, Ashfaq Shuaib, Asif Javed Butt, Chetan Vekhande, Joseph Kamtchum-Tatuene, Khurshid Khan, Maher Saqqur, Naveed Akhtar, Nida Fatima, Noman Ishaque, Radhika Nair, Sarah Razzaq대한뇌졸중학회 · 대한뇌졸중영문학회지2022 · 제24권 제1호The Impact of COVID-19 on Admissions and In-hospital Mortality of Patients With Stroke in Korea: An Interrupted Time Series Analysis김도형, 장영수, 조은별, Bai Haibin, Hwang Soo-Hee, Lee Hyejin, Lee Jin Yong, Park Seowoo대한예방의학회 · 예방의학회지2025 · 제58권 제1호Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2DPG Purwa Samatra, IA Sri Wijayanti, Kumara Tini, Ni Made Susilawathi, Putu Lohita Rahmawati대한신경과학회 · Journal of Clinical Neurology2021 · 제17권 제2호COVID-19에 의한 EMS 동반손상문준동, 양진철, 이남진사단법인 한국응급구조학회 · 한국응급구조학회지2021 · 제25권 제3호The Heart Is at Risk: Understanding Stroke-Heart-Brain Interactions with Focus on Neurogenic Stress Cardiomyopathy—A ReviewAristomenis Exadaktylos, Mairi Ziaka대한뇌졸중학회 · 대한뇌졸중영문학회지2023 · 제25권 제1호

이 간행물의 다른 논문 (13건)

Update on the Epidemiology, Pathogenesis, and Biomarkers of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and LeukoencephalopathyYi-Chu Liao, Yumi Yamamoto, 최재철, Masafumi Ihara, Yi-Chung Leepp. 12-27Relationship Between MicroRNA Signature and Arterial Stiffness in Patients With Ischemic Stroke김정민, 박광열, 이상진, 이은선, 김혜련pp. 28-35Can Artificial Intelligence Diagnose Transient Global Amnesia Using Electroencephalography Data?이동아, 박강민, Young Deok Seopp. 36-43Electrophysiologic Characteristics of Nitrous-Oxide-Associated Peripheral Neuropathy: A Retrospective Study of 76 PatientsWeishuai Li, Miao Yu, Xiuying Fang, Han Gao, Dongming Zheng, Ying Mapp. 44-51Telbivudine-Induced Myopathy: Clinical Features, Histopathological Characteristics, and Risk FactorsChien-Hung Chen, Yung-Yee Chang, King-Wah Chiu, Tsu-Kung Lin, Shun-Sheng Chen, Min-Yu Lan, Hui-Chen Lin, Tsung-Hui Hu, Shu-Fang Chenpp. 52-59
원문 보기